Details for New Drug Application (NDA): 018705
✉ Email this page to a colleague
The generic ingredient in NITROLINGUAL PUMPSPRAY is nitroglycerin. There are thirty-six drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.
Summary for 018705
Tradename: | NITROLINGUAL PUMPSPRAY |
Applicant: | Pohl Boskamp |
Ingredient: | nitroglycerin |
Patents: | 1 |
Pharmacology for NDA: 018705
Physiological Effect | Vasodilation |
Medical Subject Heading (MeSH) Categories for 018705
Suppliers and Packaging for NDA: 018705
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
NITROLINGUAL | nitroglycerin | AEROSOL;SUBLINGUAL | 018705 | NDA AUTHORIZED GENERIC | Allegis Pharmaceuticals, LLC | 28595-120 | 28595-120-12 | 1 BOTTLE in 1 CARTON (28595-120-12) / 200 SPRAY in 1 BOTTLE |
NITROLINGUAL | nitroglycerin | AEROSOL;SUBLINGUAL | 018705 | NDA AUTHORIZED GENERIC | Allegis Pharmaceuticals, LLC | 28595-120 | 28595-120-49 | 1 BOTTLE in 1 CARTON (28595-120-49) / 60 SPRAY in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | AEROSOL;SUBLINGUAL | Strength | 0.4MG/SPRAY | ||||
Approval Date: | Oct 31, 1985 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | SPRAY, METERED;SUBLINGUAL | Strength | 0.4MG/SPRAY | ||||
Approval Date: | Jan 10, 1997 | TE: | AB | RLD: | Yes | ||||
Patent: | ⤷ Sign Up | Patent Expiration: | Mar 12, 2029 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patented Use: | METHOD OF TREATING ANGINA PECTORIS |
Expired US Patents for NDA 018705
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pohl Boskamp | NITROLINGUAL PUMPSPRAY | nitroglycerin | SPRAY, METERED;SUBLINGUAL | 018705-002 | Jan 10, 1997 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription